Talk:Trifarotene

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Trifarotene.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Approval for the treatment of Ichthyosis in the EU

I’m unclear on whether this drug is approved in the EU for Ichthyosis. The source says it was first in compliance, and later out of compliance and laid out certain actions that were taken, but I can’t figure out whether it’s still approved. The only information I can find is it being approved for the treatment of acne in the EU. Ben ❯❯❯ Talk 00:38, 18 May 2021 (UTC)[reply]

Where did you get the information that it is approved at all in the EU? The source only shows the orphan drug designation documents. --ἀνυπόδητος (talk) 07:35, 18 May 2021 (UTC)[reply]

This seems to indicate it has been approved. I'm not familiar with the EU's procedure for approving drugs, but it seems that each country has to also approve it. Another source here Ben ❯❯❯ Talk 03:29, 24 May 2021 (UTC)[reply]

You are right. I didn't know that decentralised approvals are still a thing; these apparently don't show up on the EMA page. In this process, the individual countries indeed have to approve it separately, in contrast to centralised approvals, where this isn't necessary. --ἀνυπόδητος (talk) 11:10, 24 May 2021 (UTC)[reply]